Clinical TrialsSearch results
Number of results: 976
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Elucidation of clinical implication of cardiorenal anemia syndrome
- heart failure, chronic renal disease, anemia
- Matsushima Shouji
- 2024-01-22
Other
- Brightline-4: A study to test how well brigimadlin is tolerated by people with a type of cancer called dedifferentiated liposarcoma
- Dedifferentiated liposarcoma
- Hagimori Kenta
- 2024-01-18
Recruiting
- A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
- Generalized Pustular Psoriasis Erythrodermic Psoriasis
- Nihikawa Kazuko
- 2023-12-25
Completed
- Comparison of treatment outcomes of different immobilized finger positions after repair of flexor tendon rupture in Zones I and II: A nonrandomized controlled trial with historical control group
- flexor tendon rupture in Zone I and II
- Tajima Takaya
- 2023-12-25
Completed
- Clinical Pharmacology Study of KC-8025 in Japanese and Caucasian healthy adults (Phase I).
- Japanese and Caucasian healthy adult participants
- Yonemura Takuma
- 2023-12-15
Other
- An Open-label, Single-Dose Study to Investigate the Pharmacokinetics of KSP-1007 in Healthy Adult Chinese Subjects
- Hospital-acquired pneumonia including ventilator-associated pneumonia
- Tsukada Hironobu
- 2023-12-06
Recruiting
- Beamion LUNG 2: A Phase III, open-label, randomized, active-controlled, multi-centre trial evaluating orally administered BI 1810631 compared with standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations
- Unresectable, locally advanced or metastatic non-squamous NSCLC harboring HER2 TKD mutations
- Takeuchi Yoshito
- 2023-12-04
Other
- Single Administration study of Bomedemstat (MK-3543) in Healthy Japanese
- Essential thrombocythaemia
- Fujita Tomoko
- 2023-11-25
Recruiting
- Phase 3 Study to Evaluate Mezigdomide (CC-92480/BMS-986348) in Combination
with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma:
SUCCESSOR-2
- Multiple Myeloma
- Engelhardt Brian
- 2023-11-25
Completed
- Trastuzumab BS Specific Use Results Survey
- HER2 positive gastric cancer
- / / /
- 2023-11-22